Crispr Therapeutics shares owned by Macquarie Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Macquarie Group
from 13F filings
Historical chart of Macquarie Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Macquarie Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Macquarie Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-03-31 | $28k | 623 | 44.94 |
| 2022-12-31 | $1.6M | 40k | 40.66 |
| 2022-09-30 | $55M | 837k | 65.35 |
| 2022-06-30 | $5.5M | 90k | 60.77 |
| 2022-03-31 | $123k | 2.0k | 62.53 |
| 2021-12-31 | $149k | 2.0k | 75.75 |
| 2021-09-30 | $110M | 985k | 111.85 |
| 2021-06-30 | $188M | 1.2M | 161.80 |
| 2021-03-31 | $517k | 4.2k | 122.03 |
| 2020-12-31 | $25M | 160k | 153.37 |
| 2020-09-30 | $5.6M | 67k | 83.47 |
| 2020-06-30 | $7.0M | 95k | 73.55 |
| 2017-12-31 | $14k | 600 | 23.33 |